Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Top Cited Papers
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 58 (3), 1325-1335
- https://doi.org/10.1046/j.1523-1755.2000.00289.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Long-term evolution of cardiomyopathy in dialysis patientsKidney International, 1998
- Outcome and risk factors for left ventricular disorders in chronic uraemiaNephrology Dialysis Transplantation, 1996
- rHuEPO treatment improves brain and cognitive function of anemic dialysis patientsKidney International, 1991
- Improved Physical Performance after Treatment of Renal Anemia with Recombinant Human ErythropoietinNephron, 1991
- Exercise in Hemodialysis Patients after Treatment with Recombinant Human ErythropoietinNephron, 1991
- Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietinThe Lancet, 1990
- The Quality of Life of Hemodialysis Recipients Treated With Recombinant Human ErythropoietinJAMA, 1990
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietinKidney International, 1989
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Uremic cardiomyopathy: An inadequate left ventricular hypertrophyKidney International, 1987